Conversion of 2-deoxyglucose-induced growth inhibition to cell death in normoxic tumor cells

A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors

(2012) Luis E. Raez et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

2-Deoxy-d-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion

(2010) Haibin Xi et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Phosphorylation of eIF2α at Serine 51 Is an Important Determinant of Cell Survival and Adaptation to Glucose Deficiency

(2010) Hala Muaddi et al.   MOLECULAR BIOLOGY OF THE CELL

High endoplasmic reticulum activity renders multiple myeloma cells hypersensitive to mitochondrial inhibitors

(2009) Metin Kurtoglu et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Stable isotope-assisted metabolomics in cancer research

(2008) Andrew N. Lane et al.   IUBMB LIFE

2-Deoxy-d-glucose causes cytotoxicity, oxidative stress, and radiosensitization in pancreatic cancer

(2007) Mitchell C. Coleman et al.   FREE RADICAL BIOLOGY AND MEDICINE